The vast majority of research studies working to identify risk factors and prediction models for preeclampsia are focused on the pregnant woman. But what about the other half of the "placental equation"? Researchers for this study suggest that paternal health (meaning the health of the man that contributed the sperm and half the genes to the placenta and baby) should be considered when evaluating a patient’s risk for preeclampsia, too. In this study, researchers asked if paternal health – classified by characteristics of the metabolic syndrome (large waist circumference, high triglycerides, low HDL (the “good” cholesterol), increased blood pressure, and elevated blood sugar) - are linked to maternal health during pregnancy.
Researchers analyzed pregnancy outcomes in over 650,000 healthy women in the IBM Marketscan® research database (which also included data on paternal health) and found a strong relationship between likelihood of preeclampsia and a partner with 2 or more characteristics of the metabolic syndrome. The odds of preeclampsia were 21% higher for women with partners with 2 or more of these characteristics compared to women with partners with none. That means that where 5 out of 100 average women will develop preeclampsia during pregnancy, 6 out of 100 women with partners with metabolic syndrome will. This study shows that in healthy, low risk women, prepregnancy paternal health may be worth assessing to make medical decisions about prenatal care.
LINK: https://pubmed.ncbi.nlm.nih.gov/33895399/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials Finding strategies for preventing preeclampsia is a top priority in...
Masked Pregnancy-Associated Hypertension as a Predictor of Adverse Outcomes Pregnant women who have risk factors for preeclampsia may be advised by their health care provider to monitor their...
Preeclampsia Prevention by Timed Birth at Term In this study, researchers looked at different ways to find out if a pregnant woman might get preeclampsia at term (>37 weeks) and when would be...
Polygenic prediction of preeclampsia and gestational hypertension All humans have near-identical DNA sequences across the estimated 6 billion-letter code that makes up the human genome. However, slig...
Noninvasive preeclampsia prediction using plasma cell-free RNA signatures. Messenger ribonucleic acid (mRNA) is a molecule that contains the instructions to tell cells how to make proteins. mRNA is m...